Get the Stockscreener App
11.98
1.24%
-0.145
Certara Inc stock is traded at $11.98, with a volume of 433.77K.
It is down -1.24% in the last 24 hours and down -7.20% over the past month.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.
See More
Previous Close:
$12.13
Open:
$12.12
24h Volume:
433.77K
Relative Volume:
0.23
Market Cap:
$2.07B
Revenue:
$363.55M
Net Income/Loss:
$-78.68M
P/E Ratio:
-23.97
EPS:
-0.5
Net Cash Flow:
$50.74M
1W Performance:
+5.36%
1M Performance:
-7.20%
6M Performance:
+11.86%
1Y Performance:
-28.05%
1-Day Range:
$11.90
$12.19
1-Week Range:
$11.27
$12.50
52-Week Range:
$8.635
$17.75
Certara Inc Stock (CERT) Company Profile
Name
Certara Inc
Sector
Industry
Phone
(415) 237-8272
Address
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
Compare CERT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CERT
Certara Inc
|
11.98 | 2.07B | 363.55M | -78.68M | 50.74M | -0.50 |
|
VEEV
Veeva Systems Inc
|
241.94 | 38.62B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
60.21 | 11.14B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
69.80 | 9.03B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
100.26 | 7.91B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
38.73 | 7.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
Certara Inc Stock (CERT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-08-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Feb-27-25 | Initiated | TD Cowen | Buy |
| Sep-27-24 | Upgrade | UBS | Neutral → Buy |
| Apr-10-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-04-24 | Initiated | JMP Securities | Mkt Perform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-07-23 | Initiated | UBS | Neutral |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Aug-22-23 | Downgrade | Jefferies | Buy → Hold |
| Aug-10-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Apr-03-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-08-22 | Initiated | Berenberg | Buy |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-01-22 | Initiated | Piper Sandler | Overweight |
| Jan-11-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Jul-23-21 | Initiated | Robert W. Baird | Outperform |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-06-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jan-05-21 | Initiated | BofA Securities | Buy |
| Jan-05-21 | Initiated | Credit Suisse | Neutral |
| Jan-05-21 | Initiated | Jefferies | Hold |
| Jan-05-21 | Initiated | William Blair | Outperform |
View All
Certara Inc Stock (CERT) Latest News
Certara Q1 2025 slides: biosimulation leader posts strong earnings beat - Investing.com Australia
Certara signals 8-10% revenue growth for 2025, driven by software and biosimulation demand - MSN
Barclays Upgrades Certara (CERT) - Nasdaq
Certara upgraded to Overweight from Equal Weight at Barclays - TipRanks
Barclays Upgrades Certara (CERT) with Raised Price Target | CERT Stock News - GuruFocus
Barclays raises Certara stock rating, hikes PT to $14 - Investing.com
Barclays raises Certara stock rating, hikes PT to $14 By Investing.com - Investing.com India
Certara (CERT) Receives Upgrade to Overweight by Barclays Analyst | CERT Stock News - GuruFocus
Certara, Inc. (NASDAQ:CERT) Q1 2025 Earnings Call Transcript - Insider Monkey
Certara stock holds as JMP maintains Market Perform rating By Investing.com - Investing.com Nigeria
Certara’s Earnings Call Highlights Growth and Optimism - TipRanks
Certara (CERT) Receives Reiterated Market Perform Rating from JMP Securities | CERT Stock News - GuruFocus
Certara stock holds as JMP maintains Market Perform rating - Investing.com
Certara Q1 2025 Earnings Call Transcript - MarketBeat
Certara Q1 Adjusted Earnings, Revenue Increase; 2025 Outlook Reaffirmed - marketscreener.com
Certara Inc (CERT) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Certara Inc (CERT) Q1 2025 Earnings Call Highlights: Strong Reve - GuruFocus
When (CERT) Moves Investors should Listen - news.stocktradersdaily.com
Decoding Certara Inc (CERT): A Strategic SWOT Insight - GuruFocus
Earnings call transcript: Certara Q1 2025 sees strong earnings beat - Investing.com Australia
Earnings call transcript: Certara Q1 2025 sees strong earnings beat By Investing.com - Investing.com India
Certara, Inc. (CERT) Q1 Earnings and Revenues Beat Estimates - Yahoo Finance
CERT Reiterates 2025 Revenue Forecast Amid Strong Q1 Performance | CERT Stock News - GuruFocus
Certara (CERT) Exceeds Revenue Expectations in Q1 Amid Strategic Advancements | CERT Stock News - GuruFocus
Certara Reports First Quarter 2025 Financial Results | CERT Stock News - GuruFocus
Certara Reports First Quarter 2025 Financial Results - TradingView
Certara, Inc. SEC 10-Q Report - TradingView
Certara, Inc. Reports Strong Q1 2025 Financial Results with 10% Revenue Growth and Return to Profitability - Nasdaq
Earnings Flash (CERT) CERTARA Reports Q1 Revenue $106M, vs. FactSet Est of $105.1M - marketscreener.com
Certara Earnings Reveal Strong Growth: Software Revenue Soars 18% as Biosimulation Demand Accelerates - Stock Titan
Certara, Inc. Reports Strong Q1 2025 Results - TipRanks
Certara (CERT) to Release Quarterly Earnings on Monday - Defense World
Certara Inc [CERT] Records 50-Day SMA of $11.81 - knoxdaily.com
Certara Inc (CERT) Stock: A Year of Market Fluctuations - investchronicle.com
Perhaps timely catching Certara Inc (CERT) would be a good idea - Sete News
Certara to Participate in Upcoming Investor Conferences | CERT S - GuruFocus
Certara to Participate in Upcoming Investor Conferences - The Manila Times
Global Drug Development Leader Certara Sets Stage at Major Healthcare Conferences This Summer - Stock Titan
Certara Inc (CERT) Shares Gap Down to $13.745 on Apr 28 - GuruFocus
Certara Inc (CERT)’s highs and lows: A closer look at its stock price fluctuations - uspostnews.com
Keeping an Eye on Certara Inc (CERT) After Insider Trading Activity - knoxdaily.com
Certara, Inc. (CERT) Earnings Expected to Grow: Should You Buy? - MSN
Certara Inc [CERT] Records 200-Day SMA of $12.02 - knoxdaily.com
What is Certara Inc (CERT) Stock Return on Shareholders’ Capital? - Sete News
Market Momentum Report: Certara Inc (CERT)’s Negative Close at 14.25 - DWinneX
Certara, Inc. (NASDAQ:CERT) Shares Sold by Envestnet Asset Management Inc. - Defense World
Investing in Certara Inc (CERT): What You Must Know - knoxdaily.com
3 Momentum Stocks That Could Soar Post-Market Volatility - Investing.com
3 Momentum Stocks That Could Soar Post-Market Volatility - MarketBeat
Where are the Opportunities in (CERT) - news.stocktradersdaily.com
Geode Capital Management LLC Sells 10,953 Shares of Certara, Inc. (NASDAQ:CERT) - Defense World
Certara Inc Stock (CERT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Certara Inc Stock (CERT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL OFF |
Apr 01 '25 |
Option Exercise |
0.00 |
26,626 |
0 |
127,669 |
| Gallagher John E | PRESIDENT, CHIEF COMMERCAL OFF |
Apr 01 '25 |
Option Exercise |
0.00 |
42,486 |
0 |
51,731 |
| Feehery William F | CHIEF EXECUTIVE OFFICER |
Apr 01 '25 |
Option Exercise |
0.00 |
111,393 |
0 |
2,354,346 |
1.97%
0.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):